Heparanase Levels in Type 2 Diabetes Patients
Author Information
Author(s): Shafat Itay, Ilan Neta, Zoabi Samih, Vlodavsky Israel, Nakhoul Farid
Primary Institution: Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
Hypothesis
Increased heparanase levels in type 2 diabetes patients are associated with blood glucose levels.
Conclusion
Heparanase levels are significantly elevated in the urine and plasma of type 2 diabetes patients and are reduced after kidney transplantation.
Supporting Evidence
- Heparanase levels in the urine of T2DM patients were markedly elevated compared to healthy controls.
- Increased heparanase levels were also found in the plasma of T2DM patients.
- Urine heparanase was associated with elevated blood glucose levels.
Takeaway
People with type 2 diabetes have higher levels of a protein called heparanase in their urine and blood, which might be linked to their blood sugar levels.
Methodology
The study used an ELISA method to measure heparanase levels in urine and plasma from type 2 diabetes patients, kidney transplant patients, and healthy controls.
Potential Biases
Potential bias due to selection of patients from a single outpatient nephrology clinic.
Limitations
The study's findings may be influenced by the small sample size of kidney transplant patients.
Participant Demographics
The study included 29 type 2 diabetes patients (14 female, 15 male; average age 56.2 years), 14 kidney transplant patients (3 female, 11 male; average age 58.4 years), and 47 healthy volunteers (30 male, 17 female; average age 46 years).
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website